Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

NorwayBack to Norway

Clinical trials in Bodo

36 clinical trials in Bodo, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Bodo at a glance
36
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

36 trials in Bodo

Open in trial search

Chronic kidney disease

Recruiting

Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Cardiovascular disorder+2

Recruiting

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Acute myocardial infarction

Recruiting

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Triple negative breast cancer

Recruiting

Study of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Sepsis

Recruiting

Comparison of Gentamicin with Narrow-Spectrum Antibiotics versus Broad-Spectrum Antibiotics in Adult Patients with Early Sepsis

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Ampicillin Sodium
  • Sponsor:Akershus University Hospital

Pancreatic carcinoma

Recruiting

Study on Clopidogrel and Dalteparin Sodium for Preventing Blood Clots in Pancreatic Cancer Patients

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Clopidogrel
  • Sponsor:Akershus University Hospital

Amyotrophic lateral sclerosis

Recruiting

Study on the Effects of ILB and Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Riluzole
  • Sponsor:Oslo University Hospital HF

Neoplasm malignant

Recruiting

Study on Dabrafenib, Trametinib, and Imatinib for Patients with Rare and Hard-to-Treat Cancers

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Dabrafenib
  • Sponsor:Oslo University Hospital HF

Pneumonia

Recruiting

Study on the Effect of Amoxicillin in Preschool Children with Pneumonia

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Amoxicillin Trihydrate
  • Sponsor:Oslo University Hospital HF

Neoplasm malignant

Recruiting

Study on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Oslo University Hospital HF

Study on the Safety and Effectiveness of EIK1001 and Pembrolizumab for Patients with Advanced Melanoma

Recruiting
Registered drug
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Eikon Therapeutics Inc.

Immune thrombocytopenia

Recruiting

Study Comparing Avatrombopag and Rituximab for Adults with Immune Thrombocytopenia Not Responding to Corticosteroids

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Avatrombopag
  • Sponsor:Ostfold Hospital Trust

Other cities in Norway

The busiest research cities in the country

All 54 cities in Norway

Clinical research in Bodo

What the registry says about research in the country

01 Respiratory Medicine

Research focusing on pulmonary diseases and respiratory conditions, including studies on treatment approaches for idiopathic pulmonary fibrosis and advanced lung cancer therapies.

  • Pulmonary Fibrosis Treatment Studies
  • Small-Cell Lung Cancer Therapy
  • Pediatric Respiratory Infections

Clinical trials evaluating innovative treatments combining immunotherapy with conventional approaches.

02 Cardiovascular Research

Comprehensive studies addressing cardiovascular disorders, from stroke prevention to cholesterol management and acute cardiac conditions.

  • Stroke Prevention in Atrial Fibrillation
  • Acute Myocardial Infarction Management
  • Cholesterol Control Therapies

Innovative approaches in preventive cardiology and acute cardiac care interventions.

03 Oncology Studies

Advanced cancer research including precision medicine trials for various cancer types, with particular focus on melanoma and breast cancer treatments.

  • Pancreatic Cancer Therapies
  • Advanced Melanoma Treatment
  • HER2-Positive Breast Cancer

Pioneering targeted therapies and immunotherapy approaches for cancer treatment.

04 Chronic Conditions

Research addressing long-term health conditions including rheumatoid arthritis, chronic kidney disease, and obesity management.

  • Adolescent Obesity Treatment
  • Chronic Kidney Disease
  • Arthritis Management

Focus on developing effective long-term treatment strategies for chronic conditions.

Back to NorwayAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.